AMY ABERNETHY, M.D., PH.D.

Former Principal Deputy Commissioner

FDA

CHRIS ARENDT, PH.D.

CSO, Head of Research

Takeda

JAMIL BEG

Partner

SV Health Investors

LUCIANA BORIO, M.D.

Venture Partner

Arch Venture Partners

SHELLEY CHU, M.D., PH.D.

Partner, Head of Biotech

Lightspeed Ventures

MARK CURRIE, PH.D.

Venture Partner

Iaso Ventures

SIMONE FISHBURN, PH.D.

VP & Editor in Chief

BioCentury Inc.

TODD FOLEY

Managing Director

MPM BioImpact

KATHLEEN GIACOMINI, PH.D.

Dean, School of Pharmacy

UCSF

DAVID GOLDSTEIN, PH.D.

Co-founder & CEO

Actio Biosciences

JANE GROGAN, PH.D.

EVP, Head of Research

Biogen

COLIN HILL

CEO

Aitia

NAJAT KHAN, PH.D.

Chief Data Science Officer

Johnson & Johnson

SOPHIE KORNOWSKI, PHARM.D.

CEO

Boston Pharmaceuticals

OLIVIER LECLERC

Senior Partner

McKinsey & Company

JOHN LEPORE, M.D.

CEO

ProFound Therapeutics

MATHAI MAMMEN, M.D., PH.D.

Chairman & CEO

FogPharma

FIONA MARSHALL, PH.D.

President of Biomedical Research

Novartis

ANTOINE PAPIERNIK

Chairman & Managing Partner

Sofinnova Partners

KUSH PARMAR, M.D., PH.D.

Managing Partner

5AM Ventures

CARY PFEFFER, M.D.

Partner

Third Rock Ventures

ROBERT PLENGE, M.D., PH.D.

EVP, Chief Research Officer

Bristol Myers Squibb

DANIEL REICH, M.D., PH.D.

Senior Investigator, NIH Liaison

National Institute of Neurological Disorders and Stroke

KLAUS ROMERO, M.D.

CEO

Critical Path Institute

DAVID SATIJN, PH.D.

SVP, Head of Discovery

Genmab

PAUL PETER TAK, M.D., PH.D.

President and CEO

Candel Therapeutics

NIKHIL WAGLE, M.D.

VP & Global Head of Translational Medicine

Genentech

DOUGLAS WILLIAMS, PH.D.

Head of R&D

Sana Biotechnology